Mersana Therapeutics
MRSN
#8907
Rank
$0.14 B
Marketcap
$28.14
Share price
0.79%
Change (1 day)
-55.86%
Change (1 year)

Earnings for Mersana Therapeutics (MRSN)

Earnings in 2025 (TTM): -$73.62 Million USD

According to Mersana Therapeutics's latest financial reports the company's current earnings are $34.76 Million USD. In 2024 the company made an earning of -$68.78 Million USD, an increase over its 2023 earnings that were of -$0.18 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Mersana Therapeutics from 2016 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$73.62 Million7.04%
2024 -$68.78 Million-59.94%
2023 -$0.18 Billion-15.94%
2022 -$0.21 Billion20.08%
2021 -$0.18 Billion93.16%
2020 -$88.05 Million212.12%
2019 -$28.21 Million-56.1%
2018 -$64.26 Million66.02%
2017 -$38.71 Million182.53%
2016 -$13.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-$0.15 Billion 101.07%๐Ÿ‡บ๐Ÿ‡ธ USA